COSCIENS Biopharma Inc.
NASDAQ: CSCI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Anna Elizabeth Biehn
- Employees
- 40
- Headquarters
- Toronto, Canada
- IPO year
- 1996
- Market cap
- $8.6M
- Website
- https://www.cosciensbio.com
Loading CSCI…
Loading profile data…Frequently asked questions about CSCI
What does COSCIENS Biopharma Inc. (CSCI) do?
COSCIENS Biopharma Inc. is a specialized biopharmaceutical company dedicated to the global development and commercialization of innovative therapeutic and diagnostic products. Its operations extend across Canada, Switzerland, Ireland, Denmark, Germany, the United States, and other international territories. The company's flagship product is Macr...
Where does CSCI trade?
COSCIENS Biopharma Inc. (CSCI) trades on the NASDAQ Global Market.
What sector is CSCI in?
COSCIENS Biopharma Inc. (CSCI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of COSCIENS Biopharma Inc.?
Anna Elizabeth Biehn is the chief executive officer of COSCIENS Biopharma Inc. (CSCI).
Where is COSCIENS Biopharma Inc. headquartered?
COSCIENS Biopharma Inc. is headquartered in Canada.
Does CSCI pay a dividend?
COSCIENS Biopharma Inc. (CSCI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CSCI go public?
COSCIENS Biopharma Inc. (CSCI) completed its initial public offering in 1996.